AllianceBernstein
CRBU icon

AllianceBernstein’s Caribou Biosciences CRBU Stock Holding History

AllianceBernstein’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.5K Buy
+37,080
New +$73.3K ﹤0.01% 3280
2025
Q2 		– Sell
-171,560
Closed -$157K – 3255
2025
Q1 		$157K Hold
171,560
– – ﹤0.01% 2983
2024
Q4 		$273K Hold
171,560
– – ﹤0.01% 2922
2024
Q3 		$336K Hold
171,560
– – ﹤0.01% 2864
2024
Q2 		$281K Buy
171,560
+86,930
+103% +$278K ﹤0.01% 2938
2024
Q1 		$435K Sell
84,630
-1,130
-1% -$6.97K ﹤0.01% 2640
2023
Q4 		$491K Buy
85,760
+17,810
+26% +$88K ﹤0.01% 2617
2023
Q3 		$325K Hold
67,950
– – ﹤0.01% 2781
2023
Q2 		$289K Buy
67,950
+28,350
+72% +$127K ﹤0.01% 2881
2023
Q1 		$210K Buy
39,600
+4,300
+12% +$26.8K ﹤0.01% 2889
2022
Q4 		$222K Buy
35,300
+5,500
+18% +$48.9K ﹤0.01% 2975
2022
Q3 		$314K Buy
29,800
+4,700
+19% +$43.8K ﹤0.01% 2843
2022
Q2 		$136K Buy
+25,100
New +$192K ﹤0.01% 3090
2021
Q4 		– Sell
-24,488
Closed -$585K – 3303
2021
Q3 		$585K Buy
+24,488
New +$599K ﹤0.01% 2703

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein's CRBU Position: Q2 2026 in Review

AllianceBernstein opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 37,080 shares worth $70.5K. The stake represents ﹤0.01% of the portfolio and ranks #3280 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in CRBU as recently as Q1 2025.

AllianceBernstein first reported a position in CRBU in Q3 2021 and has held it in 14 quarters since. The position peaked at $585K in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • AllianceBernstein held 37,080 shares of Caribou Biosciences worth $70.5K as of Q2 2026.
  • Caribou Biosciences was a new AllianceBernstein position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3280 holding.
  • AllianceBernstein first reported a position in Caribou Biosciences in Q3 2021 and has held it in 14 quarters since.
  • AllianceBernstein's Caribou Biosciences position peaked at $585K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.